Trial intelligence / Profile preview

Intratumoral hyperthermic chemotherapy injection for peripheral non-small cell lung cancer

PACTR201702001974160Recruiting

Sponsor
Mansoura University Faculty of Medicine
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of cisplatin in non-small cell lung cancer (NSCLC) (3 arms), sponsored by Mansoura University Faculty of Medicine. Primary endpoints: Clinical evaluation, Radiological evaluation and 1 more. Started Jan 2017; status: recruiting.

02

Drugs

cisplatin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on PACTR201702001974160.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201702001974160.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call